Yunfeng nets $450m from Alibaba Health stake sale
Chinese private equity firm Yunfeng Capital trimmed its position in Alibaba Health Information Technology with an upsized block trade on Thursday, its second sale of the stock this year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts